SHANGHAI FOSUN PHARMACEUTICAL GROUP
(HKEX: 2196)

Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China.

20.760 -

-0.380 (-1.80%)
价格区间 20.760 - 21.520   (3.66%)
开盘 21.120
昨收 21.140
20.760
买盘 ('000) 58.5
20.820
卖盘 ('000) 1
成交量 ('000) 2,156.8
成交额 45,029,069
注释 -
数据延迟。最后一次更新12 Feb 2026 16:08.
数据提供商
查看所有活动


Loading Chart...

Please login to view stock data and analysis